Model Releases

A Unified DINOv2-Based Framework for LVEF Estimation, GLS Dysfunction Classification, and Early Cardiotoxicity Prediction

arXiv:2608.14750v1 Announce Type: cross Abstract: Left ventricular ejection fraction (LVEF) estimation (Task 1), global longitu-dinal strain (GLS)-based dysfunction classification (Task 2), and early

DGX agentpaper
model-releasesarxiv-cs-cv

arXiv:2608.14750v1 Announce Type: cross Abstract: Left ventricular ejection fraction (LVEF) estimation (Task 1), global longitu-dinal strain (GLS)-based dysfunction classification (Task 2), and early cardi-otoxicity prediction (Task 3) provide complementary information for cardio-oncology assessment. LVEF reflects macroscopic ventricular volume chang-es as the clinical standard, whereas GLS captures subtle myocardial defor-mation, indicating subclinical cardiotoxicity before overt LVEF decline. Fur-thermore, predicting cardiotoxicity from baseline echocardiography prior to treatment enables preventive interventions at an early stage. To address these three tasks, we employ a DINOv2-based framework with task-specific adap-tation and prediction heads. Built upon a frozen foundation encoder, the framework incorporates parameter-efficient Low-Rank Adaptation (LoRA) and temporal aggregation to learn task-specialized representations, ensuring robust generalization. Crucially, during inference, it operates in a fully cycle-detection-free and phase-free manner, requiring neither cardiac cycle seg-mentation nor explicit End-Diastolic/End-Systolic (ED/ES) annotations. Ad-ditionally, we introduce an ED/ES-guided 2D/3D hybrid multi-view regres-sion model specifically to optimize Task 1. On a patient-level split containing 1,203 training videos from 237 patients and 300 validation videos from 59 independent patients, the DINOv2-based framework achieved a mean abso-lute error (MAE) of 5.03% for Task 1, an AUC-ROC of 76.48% for Task 2, and an AUC-ROC of 70.26% for Task 3. For Task 1, the specialized ED/ES-guided model further improves performance, achieving an MAE of 4.64%. This framework demonstrates the effectiveness of foundation model repre-sentations across diverse cardio-oncology tasks and the additional benefit of physiology-guided modeling for accurate LVEF estimation.

Source: arXiv cs.CV | 2026-08-18

Loading related sources…